Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Clin Exp Pathol. 2008 Jan 1;1(5):396-402.

Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.

Author information

  • 1Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA. syxiao@utmb.edu

Abstract

Fibrosing cholestatic hepatitis (FCH) is a rapidly progressive, sometimes fatal form of liver injury. Though originally reported in liver transplant recipients with recurrent hepatitis B, it has now been recognized frequently in chronic hepatitis B or C patients who are under immunosuppression. The histopathologic hallmarks in the liver include marked hepatocytic injury, severe cholestasis, and periportal and pericellular fibrosis. The pathogenesis is largely unknown. The aim of this review is to describe the spectrum of clinical conditions in which FCH occurs, common histopathologic findings, features unique to certain underlying diseases, factors to be considered in differential diagnosis, and our current understanding of pathogenesis of this disease.

KEYWORDS:

Viral hepatitis; hepatitis B virus; hepatitis C virus; liver transplantation; pathogenesis

PMID:
18787628
[PubMed]
PMCID:
PMC2480579
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk